Repeatability of Quantitative Parameters Derived From Diffusion Tensor Imaging in Patients With Glioblastoma Multiforme

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 5, 2009, Pages 1199-1205

  Paldino, Michael J ^a   Barboriak, Daniel ^a   Desjardins, Annick ^a   Friedman, Henry S ^a   Vredenburgh, James J ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Brain; Diffusion tensor imaging; Glioma; Repeatability

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; FEMALE; GLIOBLASTOMA; HUMAN; IMAGING SYSTEM; MALE; MATHEMATICAL PARAMETERS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THREE DIMENSIONAL IMAGING; TUMOR DIAGNOSIS; TUMOR RECURRENCE; ALGORITHM; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; IMAGE ENHANCEMENT; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALGORITHMS; BRAIN NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 66149140206     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21732     Document Type: Article

References (27)

1. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-1280.
2. Barker FG Jr, Prados MD, Chang SM, et al. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 1996;84:442-448.
3. Perry JR, Cairncross JG. Glioma therapies: how to tell which work? J Clin Oncol 2003;21:3547-3549.
4. Hamstra DA, Chenevert TL, Moffat BA, et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 2005;102:16759-16764.
5. Roberts C, Issa B, Stone A, Jackson A, Waterton JC, Parker GJ. Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging 2006;23:554-563.
6. Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, Gillies RJ. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1999;1:113-117.
7. Lee KC, Hall DE, Hoff BA, et al. Dynamic imaging of emerging resistance during cancer therapy. Cancer Res 2006;66:4687-4692.
8. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005;102:5524-5529.
9. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029-2036.
10. Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997;3:1457-1466.
11. Lee KC, Hamstra DA, Bhojani MS, Khan AP, Ross BD, Rehemtulla A. Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy. Clin Cancer Res 2007;13:1839-1846.
12. Goebell E, Fiehler J, Ding XQ, et al. Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients-a combined diffusion tensor imaging and 1H-MR spectroscopy study. AJNR Am J Neuroradiol 2006;27:1426-1431.
13. Beppu T, Inoue T, Shibata Y, et al. Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas. Surg Neurol 2005;63:56-61; Discussion 61.
14. Beppu T, Inoue T, Shibata Y, et al. Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors. J Neurooncol 2003;63:109-116.
15. Stadlbauer A, Ganslandt O, Buslei R, et al. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 2006;240:803-810.
16. Ito M, Watanabe H, Kawai Y, et al. Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy. J Neurol Neurosurg Psychiatry 2007;78:722-728.
17. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. Journal Magn Reson 1996;111:209-219.
18. Perona P, Malik J. Scale-space and edge detection using anisotropic diffusion. IEEE Trans Pattern Anal Mach Intell 1990;12:629-639.
19. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-160.
20. Galbraith SM, Lodge MA, Taylor NJ, et al. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis. NMR Biomed 2002;15:132-142.
21. Sadeghi N, D'Haene N, Decaestecker C, et al. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29:476-482.
22. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 2006;24:3293-3298.
23. O'Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 2007;96:189-195.
24. Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 2003;179:641-649.
25. Hein PA, Kremser C, Judmaier W, et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 2003;45:214-222.
26. Heiervang E, Behrens TE, Mackay CE, Robson MD, Johansen-Berg H. Between session reproducibility and between subject variability of diffusion MR and tractography measures. Neuroimage 2006;33: 867-877.
27. Pfefferbaum A, Adalsteinsson E, Sullivan EV. Replicability of diffusion tensor imaging measurements of fractional anisotropy and trace in brain. J Magn Reson Imaging 2003;18:427-433.